Dominick Disabatino Audrey Crowell
January 09, 2023 | New York Law Journal
Industry Fights Back Against Restrictions on Pharmaceutical Manufacturers' Ability To Offer Drug Cost-Sharing SubsidiesIn 2022, the Office of Inspector General and at least two federal courts took a clear stance against pharmaceutical manufacturers' attempts to offer cost-sharing subsidies to Medicare beneficiaries for certain drugs, but the industry is fighting back. Pharmaceutical manufacturers and lobbying groups are challenging these administrative restrictions in a concerted effort to increase access to life-saving medications.
By Dominick DiSabatino, Audrey Crowell and Scott Liebman
15 minute read
Trending Stories
- 1'It's Not Going to Be Pretty': PayPal, Capital One Face Novel Class Actions Over 'Poaching' Commissions Owed Influencers
- 211th Circuit Rejects Trump's Emergency Request as DOJ Prepares to Release Special Counsel's Final Report
- 3Supreme Court Takes Up Challenge to ACA Task Force
- 4'Tragedy of Unspeakable Proportions:' Could Edison, DWP, Face Lawsuits Over LA Wildfires?
- 5Meta Pulls Plug on DEI Programs
More from ALM
- Scan In Progress: Litigators Leverage AI to Screen Prospective Jurors 1 minute read
- Legal Speak at General Counsel Conference East 2024: Match Group's Katie Dugan & Herrick's Carol Goodman 1 minute read
- Legal Speak at General Counsel Conference East 2024: Eric Wall, Executive VP, Syllo 1 minute read